Redwood Investment Management LLC Invests $1.17 Million in HCA Healthcare, Inc. $HCA

Key Points

• Redwood Investment Management opened a $1.17 million position in HCA Healthcare during the second quarter by purchasing 3,010 shares. Institutional investors and hedge funds collectively own 62.73% of the company.
• HCA Healthcare exceeded quarterly expectations, reporting $7.59 in EPS and $20.23 billion in revenue, with revenue rising 8.7% year over year.
• The company declared a quarterly dividend of $0.78, equal to $3.12 annually and a 0.7% yield. Analysts maintain a “Moderate Buy” consensus with an average price target of $462.64, above the reported share price of $426.36.

Redwood Investment Management LLC bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 3,010 shares of the company's stock, valued at approximately $1,174,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Palisade Asset Management LLC acquired a new stake in shares of HCA Healthcare during the third quarter worth about $26,000. MidFirst Bank purchased a new stake in HCA Healthcare in the 2nd quarter valued at $28,000. Clearstead Trust LLC purchased a new position in HCA Healthcare during the 2nd quarter worth $29,000. Ares Financial Consulting LLC purchased a new stake in shares of HCA Healthcare in the fourth quarter valued at about $31,000. Finally, Cedar Mountain Advisors LLC purchased a new position in shares of HCA Healthcare during the first quarter worth about $33,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Stock Down 0.6%

Shares of HCA opened at $426.36 on Thursday. The company has a market capitalization of $92.31 billion, a PE ratio of 14.27, a P/E/G ratio of 1.49 and a beta of 1.10. HCA Healthcare, Inc. has a 52-week low of $353.99 and a 52-week high of $556.52. The company has a 50-day simple moving average of $399.36 and a 200-day simple moving average of $442.21.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $7.56 by $0.03. The company had revenue of $20.23 billion during the quarter, compared to analysts' expectations of $19.76 billion. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The firm's quarterly revenue was up 8.7% compared to the same quarter last year. During the same period last year, the company posted $6.84 earnings per share. On average, research analysts anticipate that HCA Healthcare, Inc. will post 29.42 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be issued a $0.78 dividend. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 annualized dividend and a yield of 0.7%. HCA Healthcare's dividend payout ratio is 10.45%.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the company. UBS Group lowered their target price on HCA Healthcare from $635.00 to $579.00 and set a "buy" rating on the stock in a research note on Monday, July 27th. Royal Bank Of Canada reaffirmed an "outperform" rating and set a $435.00 price target on shares of HCA Healthcare in a report on Monday, July 27th. Oppenheimer cut their price objective on shares of HCA Healthcare from $520.00 to $485.00 and set an "outperform" rating for the company in a research report on Monday, July 27th. Deutsche Bank Aktiengesellschaft set a $476.00 target price on shares of HCA Healthcare in a report on Monday, July 27th. Finally, KeyCorp reduced their price objective on shares of HCA Healthcare from $475.00 to $435.00 and set an "overweight" rating for the company in a research report on Monday, July 27th. Fourteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, HCA Healthcare currently has a consensus rating of "Moderate Buy" and an average target price of $462.64.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source